Second trimester ultrasound screening for chromosomal abnormalities
Tóm tắt
The use of prenatal ultrasound has proven efficacious for the prenatal diagnosis of chromosomal abnormalities. The first sonographic sign of Down syndrome, the thickened nuchal fold, was first described in 1985. Since that time, multiple sonographically‐identified markers have been described as associated with Down syndrome. The genetic sonogram, involving a detailed search for sonographic signs of aneuploidy, can be used to both identify fetuses at high risk for aneuploidy and, when normal, can be used to decrease the risk for aneuploidy for a pregnancy when no sonographic markers are identified. Combining the genetic sonogram with maternal serum screening may be the best method of assessing aneuploidy risk for women who desire such an assessment in the second trimester. Trisomy 18, Trisomy 13, and triploidy are typically associated with sonographically identified abnormalities and have a high prenatal detection rate. The use of the described sonographic signs in low‐risk women requires further investigation, however, patients at increased risk for aneuploidy due to advanced maternal age or abnormal serum screening can benefit from a genetic sonogram screening for sonographic signs of aneuploidy to adjust their baseline risk of an affected fetus. Copyright © 2002 John Wiley & Sons, Ltd.
Từ khóa
Tài liệu tham khảo
Benacerraf BR, 1990, Fetal pyelectasis: a possible association with Down syndrome, Obstet Gynecol, 76, 58
Birnholz JC, 1988, Fetal ear length, Pediatrics, 81, 555
Bromley B, 1994, Is fetal hyperechoic bowel on second‐trimester sonogram an indication for amniocentesis?, Obstet Gynecol, 83, 647
Brumfield CG, 1989, Sonographic measurements and ratios in fetuses with Down syndrome, Obstet Gynecol, 73, 644
Corteville JE, 1992, Fetal pyelectasis and Down syndrome: is genetic amniocentesis warranted?, Obstet Gynecol, 79, 770
Crane JP, 1991, Sonographically measured nuchal skinfold thickness as a screening tool for Down syndrome: results of a prospective clinical trial, Obstet Gynecol, 77, 533
Dicke JM, 1992, Sonographically detected hyperechoic fetal bowel: significance and implications for pregnancy management, Obstet Gynecol, 80, 778
Dicke JM, 1989, Fetal biometry as a screening tool for the detection of chromosomally abnormal pregnancies, Obstet Gynecol, 74, 726
Donnenfeld AE, 1994, Prospective multicenter study of second‐trimester nuchal skinfold thickness in unaffected and Down syndrome pregnancies, Obstet Gynecol, 84, 844
Fakhry J, 1985, Increased echogenicity in the lower fetal abdomen: a common normal variant in the second trimester, J Ultrasound Med, 5, 489, 10.7863/jum.1986.5.9.489
Johnson MP, 1995. Combining humerus and femur length for improved ultrasonographic identification of pregnancies at increased risk for trisomy 21, Am J Obstet Gynecol, 172, 1229, 10.1016/0002-9378(95)91484-6
Jones KL, 1997, Smith's Recognizable Patterns of Human Malformation
Lettieri L, 1993, Ear length in second‐trimester aneuploid fetuses, Obstet Gynecol, 81, 57
Lynch L, 1989, Ultrasound detection of Down syndrome: is it really possible?, Obstet Gynecol, 73, 267
Nyberg DA, 1993, Prenatal sonographic findings of trisomy 18: review of 47 cases, J Ultrasound Med, 2, 103, 10.7863/jum.1993.12.2.103
Snijders RJM, 1996, Ultrasound Markers for Fetal Chromosomal Defects